World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: TCTR
Last refreshed on: 29 April 2024
Main ID:  TCTR20161009003
Date of registration: 09/10/2016
Prospective Registration: No
Primary sponsor: Ratchadapisek Sompoch Endowment Fund Chulalongkorn university
Public title: Sensitivity and Specificity of the New Visual Field Screening Software for Diagnosing Hemianopia
Scientific title: Sensitivity and Specificity of the New Visual Field Screening Software for Diagnosing Hemianopia
Date of first enrolment: 01/08/2016
Target sample size: 80
Recruitment status: Completed
URL:  https://www.thaiclinicaltrials.org/show/TCTR20161009003
Study type:  Observational
Study design:   
Phase:  N/A
Countries of recruitment
Thailand
Contacts
Name: Patcharaporn    Jaru-ampornpan
Address:  84/40 Sukhumvit55 Wattana 10110 Bangkok Thailand
Telephone: 0867769179
Email: odddao@gmail.com
Affiliation:  Chulalongkorn University
Name: Patcharaporn    Jaru-ampornpan
Address:  84/40 Sukhumvit55 Wattana 10110 Bangkok Thailand
Telephone: 0867769179
Email: odddao@gmail.com
Affiliation:  Chulalongkorn University
Key inclusion & exclusion criteria
Inclusion criteria: Age more than 18 years old
BCVA better than 20/200 in both eyes


Exclusion criteria: Documented cognitive impairment or visual neglect
Unable to complete visual field test by physical and mental disorder
Unreliable SAP result (false positive or false negative more than 33%; or fixation loss more than 20%)


Age minimum: 18 Years
Age maximum: 100 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Sensitivity and specificity
Hemianopia
Visual field
Screening
Diagnosis
Hemianopia
Sensitivity and specificity
Hemianopia
Visual field
Screening
Diagnosis
Intervention(s)
Hemianopia
Diagnostic
Patients who were suspected having hemianopia
Primary Outcome(s)
Sensitivity and specificity of new visual field screening software 1 year sensitivity and specificity
Secondary Outcome(s)
inter-observer reliability, Point-by-point accuracy, test duration and patient’s satisfaction 1 year Kappa coefficient, patient satisfaction score
Secondary ID(s)
Source(s) of Monetary Support
Ratchadapisek Sompoch Endowment Fund Chulalongkorn university
Secondary Sponsor(s)
์None
Ethics review
Status:
Approval date:
Contact:
Results
Results available:
Date Posted:
Date Completed: 31/12/2016
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history